Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease

Journal of Clinical Immunology

Volumn 16, Issue 3, 1996, Pages 144-150

  Reimund, J M ^a,b,c   Wittersheim, C ^a   Dumont, S ^b   Muller, C D ^d   Baumann, R ^a   Poindron, P ^b   Duclos, B ^a,c  

^a HÔPITAL DE HAUTEPIERRE   (France)

^b Dept d'Immunol I   (France)

^c INSERM   (France)

^d Laboratoire de Biophysique   (France)

Author keywords

Crohn's disease; Cytokines; Inflammation; Organ cultures; Ulcerative colitis

Indexed keywords

CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOLOGY; HUMAN; INTESTINE MUCOSA; LAMINA PROPRIA; MALE; ORGAN CULTURE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADULT; AGED; COLITIS, ULCERATIVE; CROHN DISEASE; CYTOKINES; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-6; INTESTINAL MUCOSA; MALE; MIDDLE AGED; ORGAN CULTURE TECHNIQUES; PROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029889689     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01540912     Document Type: Article

References (28)

1. Cominelli F, Nast CC, Duchini A, Lee M: Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis. Gastroenterology 103:65-71, 1992
2. Schreiber S, Heinig T, Panzer V, Reinking R, Bouchard A, Stahl PD, Raedler A: Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease. Gastroenterology 108:21-33, 1995
3. Van Hees PAM, Van Elteren PH, Van Lier HJJ, Van Tongeren JHM: An index of inflammatory activity in patients with Crohn's disease. Gut 21:279-286, 1980
4. Truelove SC, Witts LJ: Cortisone in ulcerative colitis. Final report on a therapeutic trial. Br Med J 2:1041-1048, 1955
5. Wardle TD, Hall L, Turnberg LA: Use of coculture of colonic mucosal biopsies to investigate the release of eicosanoids by inflamed and uninflamed mucosa from patients with inflammatory bowel disease. Gut 33:1644-1651, 1992
6. Bull DM, Bookman MA: Isolation and functional characterization of human intestinal mucosal lymphoid cells. J Clin Invest 59:966-974, 1977
7. Riley SA, Mani V, Goodman MJ, Dutt S, Herd ME: Microscopic activity in ulcerative colitis: what does it mean? Gut 32:174-178, 1991
8. Kenney JS, Masada MP, Eugui EM, Delustro BM, Mulkins MA, Allison AC: Monoclonal antibodies to human recombinant interleukin 1 (IL1) β: Quantification of IL1β and inhibition of biological activity. J Immunol 138:4236-4242, 1987
9. Stevens C, Walz G, Singaram C, Lipman ML, Zanker B, Muggia A, Antonioli D, Peppercorn MA, Strom TB: Tumor necrosis factor-α, interleukin-1β, interleukin-6 expression in inflammatory bowel disease. Digest Dis Sci 37:818-826, 1992
10. Isaacs KL, Sartor IR, Haskill S: Cytokine messenger RNA profiles in inflammatory bowel disease mucosa detected by polymerase chain reaction amplification. Gastroenterology 103:1587-1595, 1992
11. MacDonald TT, Hutchings P, Choy M, Murch S, Cooke A: Tumor necrosis factor alpha and interferon gamma production measured at the single cell level in normal and inflammed human intestine. Clin Exp Immunol 80:301-305, 1990
12. Breese EJ, Michie CA, Nicholls SW, Murch SH, Williams CB, Domizio P, Walker-Smith JA, McDonald TT: Tumor necrosis factor-α producing cells in the intestinal mucosa of children with inflammatory bowel disease. Gastroenterology 106:1455-1466, 1994
13. Murch SH, Braegger CP, Walker-Smith JA, MacDonald TT: Location of tumor necrosis factor a by immunohistochemistry in chronic inflammatory bowel disease. Gut 34:1705-1709, 1993
14. Jones SC, Haidar A, Hagan P, Crabtree JE, Banks RE, Axon ATR, Dixon MF, Whicher JT: Cytokine production in the mucosa of patients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 5:607-612, 1993
15. Autschbach F, Schürmann G, Qiao L, Merz H, Wallich R, Meuer SC: Cytokine messenger RNA expression and proliferation status of intestinal mononuclear cells in noninflamed gut and Crohn's disease. Virchows Arch 426:51-61, 1995
16. + T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 179:589-600, 1994
17. + T cells. Immunity 1:553-562, 1944
18. Van Dullemen HM, Van Deventer SJH, Hommes DW, Bijl HA, Jansen J, Tytgat GNJ, Woody J: Treatment of Crohn's disease with anti-tumor necrosis factor chymeric monoclonal antibody (cA2). Gastroenterology 109:129-135, 1995
19. Yougman KR, Simon PhL, West GA, Cominelli F, Rachmilewitz D, Klein JS, Fiocchi C: Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells. Gastroenterology 104:749-758, 1993
20. Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, McDermott RP, Raedler A: Enhanced secretion of tumor necrosis factor-alpha, IL-6, and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 94:174-181, 1993
21. Mahida YR, Wu K, Jewell DP: Enhanced production of interleukin 1 beta by mononuclear cells isolated from mucosa with active ulcerative colitis or Crohn's disease. Gut 30:835-838, 1989
22. Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D: Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease. Gut 31:686-689, 1990
23. Brynskov J, Tvede N, Anderson CB, Vilien M: Increased concentration of interleukin-1-β, interleukin-2, and soluble interleukin-2 receptor in endoscopical mucosal biopsy specimens with active inflammatory bowel disease. Gut 33:55-58, 1992
24. McCabe RP, Secrist H, Botney M, Egan M, Peters MG: Cytokine mRNA expression in intestine from normal and inflammatory bowel disease patients. Clin Immunol Immunopathol 66:52-58, 1993
25. Nishiyama T, Mitsuyama K, Toyonaga A, Sasaki E, Tanikawa K: Colonic mucosal interleukin 1 receptor antagonist in inflammatory bowel disease. Digestion 55:368-373, 1994
26. Casini-Raggi V, Kam L, Chong YJT, Fiocchi C, Pizarro TT, Cominelli F: Mucosal imbalance of IL1 and IL1 receptor antagonist in inflammatory bowel disease. J Immunol 154:2434-2440, 1995
27. Mitsuyama K, Sasaki H, Toyonaga A, Ikeda H, Tsuruta O, Irie A, Arima N, Oriishi T, Harada K, Fujisaki K, Sata M, Tanikawa K: Colonic mucosal interleukin-6 in inflammatory bowel disease. Digestion 50:104-111, 1991
28. Kusugami K, Fukatsu A, Tanimoto M, Shinoda M, Haruta JI, Kuroiwa A, Ina K, Kanayama K, Ando T, Matsuura T, Yamaguchi T, Morise K, Ieda M, Iokawa H, Ishihara A, Sarai A: Elevation of interleukin-6 in inflammatory bowel disease is macrophage- and epithelial cell-dependent. Digest Dis Sci 40:949-959, 1995